CIRM has appointed Kevin Xu to its Independent Citizens’ Oversight Committee, the agency’s governing board.

Xu is CEO of MEBO International, which manages “Human Body Regenerative Restoration Science,” and Skingenix, a California‑based regenerative drug‑development company. “It is a privilege to join CIRM’s board,” Xu said. “I look forward to working with experts dedicated to advancing science and improving lives.”

Xu brings extensive leadership experience. Former Governor Jerry Brown appointed him to the California‑China Trade and Investment Advisory Group. He is also on an advisory board of the California‑China Trade Office. He serves as Executive Board member and Co‑Chair of the International Committee of the Bay Area Council, sits on the Los Angeles County Mental Health Commission, and is a member of the U.S. Chamber of Commerce’s International Policy Committee.

“We are delighted to welcome Kevin to the ICOC,” said Vito Imbasciani, PhD, MD, Chair of the CIRM Board. “His accomplishments, passion for innovation, and commitment to advancing science align with our mission.”

Xu also serves on the Clinton Global Initiative, the Forbes Non‑Profit Council, the Fortune CEO Initiative, and the Young Entrepreneur Council. He founded the National Rongxiang Xu Foundation, the Human Heritage Project, and California Fight Against Coronavirus. He is director of the Beijing Rongxiang Regenerative Medicine Laboratory and President of the International Society of Regenerative Medicine and Wound Repair.

Xu earned a BA in neuroscience from the University of Southern California, where he received the USC Young Alumni Merit Award.